+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Middle East and Africa Human Leukocyte Antigen Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and service, Technology, and End User

  • PDF Icon

    Report

  • 145 Pages
  • September 2022
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5668482
UP TO OFF until Mar 31st 2024
The Middle East & Africa human leukocyte antigen (HLA) testing market is expected to grow from US$ 35.78 million in 2022 to US$ 52.59 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2022 to 2028.

Despite the development of novel technological approaches such as optimized chemotherapy regimens, targeted therapies, and radiotherapy, patients suffering from many diseases still present poor survival outcomes. Technological advancements in histocompatibility have systematically addressed the issues related to the specificity of lymphocyte cross-matching. Treating a wide range of malignant and nonmalignant diseases requires hematopoietic stem cell transplantation (HSCT) as the last therapeutic resort. The HLA testing approach can help determine if the class I and II antibodies lead to a cross-match. The information obtained from the application of such sensitive and specific technologies can be used to predict cross-match results for highly sensitized patients.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa human leukocyte antigen (HLA) testing market growth at a notable CAGR during the forecast period.

Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Segmentation

The Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country.
  • Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Middle East & Africa human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others.
  • Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others.
  • Based on country, the Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa.

Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market - Companies Mentioned

THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; and Takara Bio Inc. are among the major companies operating in the Middle East & Africa human leukocyte antigen (HLA) testing market.
Frequently Asked Questions about the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market

What is the estimated value of the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market?

The Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market was estimated to be valued at $35.78 Million in 2022.

What is the growth rate of the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market?

The growth rate of the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market is 6.6%, with an estimated value of $52.59 Million by 2028.

What is the forecasted size of the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market?

The Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market is estimated to be worth $52.59 Million by 2028.

Who are the key companies in the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market?

Key companies in the Middle Eastern and African Human Leukocyte Antigen (HLA) Testing Market include THERMO FISHER SCIENTIFIC INC., CareDx, QIAGEN, Illumina, Inc., Bio, Rad Laboratories, Inc., F. HOFFMANN, LA ROCHE LTD. and Takara Bio Inc..

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - By Product and Services
1.3.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - By Technology
1.3.3 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - By End User
1.3.4 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - By country
2. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa - PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market -Analysis
6.1 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
7. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 - by Product and Services
7.1 Overview
7.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.2.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Technology
8.1 Overview
8.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.2.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
8.2.1.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by End User
9.1 Overview
9.2 Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.2.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by country
10.1 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market
10.1.1 Overview
10.1.2 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.1.3.1 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.1 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.1.2 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.1.3 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.1.3.1 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.1.4 Saudi Arabia: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.3.2 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.1 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.2.2 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.2.3 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.2.3.1 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.2.4 UAE: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.3.3 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.1 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.3.2 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.3.3 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.3.3.1 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.3.4 South Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.3.4 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.4.1 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3.4.2 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.3.4.3 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.4.3.1 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.3.4.4 Rest of Middle East & Africa: Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
11. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 CareDx
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. HOFFMANN-LA ROCHE LTD.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takara Bio Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • THERMO FISHER SCIENTIFIC INC.
  • CareDx
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. HOFFMANN-LA ROCHE LTD.
  • Takara Bio Inc.